摘要
目的:观察孟鲁司特联合盐酸丙卡特罗治疗咳嗽变异性哮喘(CVA)的疗效。方法:100例咳嗽变异性哮喘患者随机分为观察组和对照组各50例,观察组采用孟鲁司特联合盐酸丙卡特罗治疗,对照组仅用盐酸丙卡特罗(美普清)治疗,观察两组治疗效果。结果:观察组总有效率明显高于对照组,两组比较,差异有统计学意义(χ2=19.569,P<0.05)。结论:孟鲁司特联合盐酸丙卡特罗治疗CVA疗效确切,值得临床推广。
Objective：To observe the efficacy of Montelukast and Procaterol Hydrochloride in the treatment of cough variant asthma（CVA）.Methods：100 patients with cough variant asthma were randomly divided into observation group and control group,50 cases of each group,the observation group treated with Montelukast and Procaterol Hydrochloride,the control group treated with Procaterol Hydrochloride,the efficacy of two groups were observed.Results：The total effective rate of observation group was significantly higher than the control group,the differences was statically significant between two groups（χ2=19.569,P 0.05）.Conclusion：Montelukast and Procaterol Hydrochloride in the treatment of CVA is effective,worthy of promotion.
出处
《中国医药导报》
CAS
2010年第27期57-58,共2页
China Medical Herald
